REMUS
REMUS PHARMACEUTICALS LHealthcare
LTP
983.5
CHG · %
+32.35 (+3.40%)
VOL · TODAY
13.30K
PREV CLOSE
951.15
Today's range955 · 989.9
983.5
52-week range580 · 1,007
983.5
Loading candles…
Remus Pharma Ltd, incorporated in 2015, operates within the pharmaceutical industry primarily focusing on the trading and export of active pharmaceutical ingredients (API) and finished formulations. The company also provides technical consultancy services and engages in the marketing and distribution of finished dosage formulations. Serving various therapeutic segments, Remus Pharma concentrates on export markets. It employs a decentralized manufacturing approach by collaborating with third-party manufacturers. The company does not have publicly listed shares or reported subsidiaries and its key management and founding personnel are not specified.
REMUS is not part of any active scan today.
This page is a live market overview for REMUS PHARMACEUTICALS L (REMUS) on the NSE. As a listed security, REMUS PHARMACEUTICALS L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for REMUS before placing trades on tick2trade.
As of the latest feed, REMUS last traded at ₹983.5 on NSE, up ₹32.35 (3.40%) from the previous close of ₹951.15. Today's session range is ₹955 – ₹989.9, against a 52-week band of ₹580 – ₹1,007. Traded volume today stands at 13.30K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, upcoming corporate events for REMUS in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether REMUS is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for REMUS PHARMACEUTICALS L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in REMUS. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated REMUS option chain page linked from this overview.
// similar in healthcare323 total